Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001415889-24-008033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.04 | -4,067 | 1,960 | -67% | -$101.8K |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +4,067 | 3,976 | New | +$8,703 |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -4,067 | 53.3K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | S | D | 2,016 | $25.02 | 1,960 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.08, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2024-03-12 | S | D | 2,051 | $25.05 | 1,960 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2024-03-12 | M | A | 2,051 | $2.14 | 4,011 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-13 | M | A | 2,016 | $2.14 | 3,976 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-03-13 | M | D | 2,016 | $0.00 | 51,263 | D | $2.14 · — to 2031-04-01 | 2,016 Common Stock | (F4) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-03-12 | M | D | 2,051 | $0.00 | 53,279 | D | $2.14 · — to 2031-04-01 | 2,051 Common Stock | (F4) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |